Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Baseline Cost Would Be $728 Bil. Over 10 Years For 50% Subsidy

Executive Summary

A Medicare prescription drug benefit that covers 50% of drug spending for all enrollees would cost $728 bil. from 2002 to 2011, Congressional Budget Office Director Dan Crippen testified during a Senate Finance Committee hearing March 22.

You may also be interested in...



Medicare Rx Premiums Should Be Based On Ability To Pay, Sen. Grassley Says

Premiums for a prescription drug benefit under Medicare should be based on beneficiaries' ability to pay, Sen. Grassley (R-Iowa) told an April 3 press briefing.

PBM Rules Are Pivotal Point Of Medicare Rx Debate, Breaux Tells PhRMA

The structure of competition among PBMs is a key point for industry to weigh in on during the Medicare drug benefit debate, Sen. Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting March 31 in Naples, Fla.

Medicare Rx Premiums Should Be Based On Ability To Pay, Sen. Grassley Says

Premiums for a prescription drug benefit under Medicare should be based on beneficiaries' ability to pay, Sen. Grassley (R-Iowa) told an April 3 press briefing.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel